Mexico pharma production incentives may not ensure medicine supply

An opinion piece argues that Mexico's pharmaceutical production incentives may not improve medicine availability unless accompanied by timely procurement and efficient distribution. The claim is an analytical argument, not a factual event, and reflects ongoing concerns about drug supply in Mexico.